Pharmaceuticals, Biotechnology and Life Sciences
TERN-101 Demonstrated Potency as an Agonist of FXR Nuclear Hormone Receptor TERN-201 Demonstrated Potency as an Inhibitor of SSAO (VAP-1)…
NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES VANCOUVER, British Columbia–(BUSINESS WIRE)–Sproutly Canada, Inc. (CSE: SPR) (OTCQB:…
Jianjun Chen, Ph.D., has been named the Simms/Mann Family Foundation Chair in Systems Biology. DUARTE, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CityofHope?src=hash" target="_blank"gt;#CityofHopelt;/agt;–Jianjun Chen,…
25-year life sciences industry veteran to join September 2019 PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/LifeSciences?src=hash" target="_blank"gt;#LifeScienceslt;/agt;–Veeva Systems (NYSE:VEEV) today announced that Tom…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that a three-member panel of the European Patent Office’s…
OSAKA, Japan & AMSTERDAM, NL–(BUSINESS WIRE)–Shionogi & Co., Ltd (hereafter “Shionogi”) announces that the Marketing Authorisation Application (MAA) submission for…
Additional treatment modality would provide greater choice in how patients receive gut-selective biologic vedolizumab Vedolizumab set to be the only…
Data Presented at 2019 AACR Annual Meeting Supports Novel Conditionally Active Biologics CAR-T Technology ATLANTA–(BUSINESS WIRE)–F1 Oncology, Inc., a biotechnology…
Label Updated to Include Reduction in Exacerbations and Major Adverse Cardiovascular Event Safety Data in Cardiovascular-Risk COPD Patients MORRISVILLE, N.C.–(BUSINESS…